S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Idera Pharmaceuticals and The Myositis Association Join Forces to Advance the Clinical Development of a Novel TLR Antagonist, IMO-8400, for the Treatment of Myositis|
|EXCITE ISR Proves Superiority in Safety, Efficacy of Laser Atherectomy With PTA vs. PTA Alone; Data Presented at TCT 2014|
|Idera Pharmaceuticals Reports Second Quarter 2014 Financial Results and Provides Corporate Update|
|Spectranetics' EXCITE ISR Data to Be Presented at Transcatheter Cardiovascular Therapeutics (TCT) Late-Breaking Clinical Trial Session in Washington, D.C.|
|Spectranetics Announces FDA Clearance of Peripheral Laser Atherectomy Devices for In-Stent Restenosis|
|Soligenix Advances Development of a Heat Stable Rapidly Acting Anthrax Vaccine VeloThrax™|
|Dynavax Reports Second Quarter 2014 Financial Results and Safety and Pharmacodynamic Results for Asthma and Lupus Drug Candidates|
|Idera Pharmaceuticals and Collaborators Publish Promising Preclinical Data Targeting microRNA with Gene Silencing Oligonucleotide Technology|
|Idera Pharmaceuticals to Host Conference Call and Webcast to Report Second Quarter 2014 Financial Results|
|Dynavax Completes Enrollment of Phase 3 Study of HEPLISAV-B(TM)|
Click above to view more mutual fund data and stats for tlr - Teslin River Resources Corp.